Literature DB >> 16771859

Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.

Cecilia Oderup1, Lukas Cederbom, Anna Makowska, Corrado M Cilio, Fredrik Ivars.   

Abstract

We have previously demonstrated that CD4+ CD25+ natural regulatory T cells (Treg cells) induce down-modulation of CD80 and CD86 (B7) molecules on dendritic cells (DCs) in vitro. In this report we show that the extent of down-modulation is functionally significant because Treg-cell conditioned DCs induced poor T-cell proliferation responses. Further, we report that down-modulation was induced rapidly and was inhibited by blocking cytotoxic T lymphocyte antigen-4 (CTLA-4), which is constitutively expressed by the Treg cells. Even though Treg cells have previously been reported to kill antigen-presenting cells, the down-modulation was not due to selective killing of DCs expressing high level of the costimulatory molecules. We propose that Treg cells down-modulate B7-molecules on DCs in a CTLA-4-dependent way, thereby enhancing suppression of T-cell activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771859      PMCID: PMC1782280          DOI: 10.1111/j.1365-2567.2006.02362.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  51 in total

1.  Thymocyte development is normal in CTLA-4-deficient mice.

Authors:  C A Chambers; D Cado; T Truong; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Anergic T cells effect linked suppression.

Authors:  L Frasca; P Carmichael; R Lechler; G Lombardi
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

3.  Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis.

Authors:  L Lu; C A Bonham; F G Chambers; S C Watkins; R A Hoffman; R L Simmons; A W Thomson
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

4.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

5.  Anergic T cells as suppressor cells in vitro.

Authors:  G Lombardi; S Sidhu; R Batchelor; R Lechler
Journal:  Science       Date:  1994-06-10       Impact factor: 47.728

6.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

7.  Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development.

Authors:  A Kumanogoh; X Wang; I Lee; C Watanabe; M Kamanaka; W Shi; K Yoshida; T Sato; S Habu; M Itoh; N Sakaguchi; S Sakaguchi; H Kikutani
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

8.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

Authors:  William J Grossman; James W Verbsky; Winfried Barchet; Marco Colonna; John P Atkinson; Timothy J Ley
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

9.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

10.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

View more
  117 in total

1.  Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells.

Authors:  Xuguang Tai; François Van Laethem; Leonid Pobezinsky; Terry Guinter; Susan O Sharrow; Anthony Adams; Larry Granger; Michael Kruhlak; Tullia Lindsten; Craig B Thompson; Lionel Feigenbaum; Alfred Singer
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

Review 2.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Regulatory T cells and Atherosclerosis.

Authors:  Jahaira Lopez Pastrana; Xiaojin Sha; Anthony Virtue; Jietang Mai; Ramon Cueto; In Ae Lee; Hong Wang; Xiao-Feng Yang
Journal:  J Clin Exp Cardiolog       Date:  2012-10-08

Review 4.  Regulatory T cells: roles of T cell receptor for their development and function.

Authors:  Naganari Ohkura; Shimon Sakaguchi
Journal:  Semin Immunopathol       Date:  2010-02-24       Impact factor: 9.623

Review 5.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

6.  CD4+CD126low/- Foxp3+ Cell Population Represents a Superior Subset of Regulatory T Cells in Treating Autoimmune Diseases.

Authors:  Ye Chen; Zhenjian Xu; Rongzhen Liang; Julie Wang; Anping Xu; Ning Na; Bin Li; Ruoning Wang; Miller Joseph; Nancy Olsen; Willa Hsueh; Song Guo Zheng
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

7.  Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function.

Authors:  Dat Q Tran; Deborah D Glass; Gulbu Uzel; Dirk A Darnell; Christine Spalding; Steven M Holland; Ethan M Shevach
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 8.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

Review 9.  To affinity and beyond: harnessing the T cell receptor for cancer immunotherapy.

Authors:  Jessica E Thaxton; Zihai Li
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 10.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.